cis-Urocanic acid
CAS: 7699-35-6
Ref. 3D-HAA69935
1mg | Ausgelaufen | ||
2mg | Ausgelaufen | ||
5mg | Ausgelaufen | ||
10mg | Ausgelaufen | ||
25mg | Ausgelaufen | ||
50mg | Ausgelaufen |
Produktinformation
- (2Z)-3-(1H-Imidazol-5-yl)-2-propenoic acid
- 2-Propenoic acid, 3-(1H-imidazol-5-yl)-, (2Z)-
- 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, (Z)-
- 2-Propenoic acid, 3-(1H-imidazol-4-yl)-, (2Z)-
- Imidazole-4-acrylic acid, (Z)-
cis-Urocanic acid is an experimental drug that has been shown to have significant interactions with transcription-polymerase chain reactions in vitro. cis-Urocanic acid inhibits the growth of skin cancer cells after UVB irradiation. It also inhibits angiogenic factors, lymphocyte transformation, and uvb-induced urothelial carcinoma cell proliferation. cis-Urocanic acid may be a useful treatment for skin cancer and uvb-induced urothelial carcinoma due to its inhibition of transcription-polymerase chain reactions and cell proliferation.